BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16382211)

  • 1. Interactions between neuroleptics and CYP2C6 in rat liver--in vitro and ex vivo study.
    Haduch A; Ogórka T; Boksa J; Daniel WA
    Pharmacol Rep; 2005; 57(6):872-7. PubMed ID: 16382211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of cytochrome P450 CYP2B in rat liver during neuroleptic treatment.
    Haduch A; Wójcikowski J; Daniel WA
    Pharmacol Rep; 2007; 59(5):606-12. PubMed ID: 18048963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct effects of neuroleptics on the activity of CYP2A in the liver of rats.
    Haduch A; Wójcikowski J; Daniel WA
    Pharmacol Rep; 2005; 57(6):867-71. PubMed ID: 16382210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
    Daniel WA; Haduch A; Wójcikowski J
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of neuroleptics on cytochrome P450 2C11 (CYP2C11) in rat liver.
    Haduch A; Wójcikowski J; Daniel WA
    Pharmacol Rep; 2011; 63(6):1491-9. PubMed ID: 22358097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
    Daniel WA; Kot M; Wójcikowski J
    Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatment.
    Daniel WA; Haduch A; Syrek M; Boksa J
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):580-7. PubMed ID: 16503401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of classic and atypical neuroleptics on cytochrome P450 3A (CYP3A) in rat liver.
    Wójcikowski J; Haduch A; Daniel WA
    Pharmacol Rep; 2012; 64(6):1411-8. PubMed ID: 23406751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of cytochrome P-450 isoenzymes to the metabolism of phenothiazine neuroleptics.
    Daniel WA; Syrek M; Haduch A
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):371-7. PubMed ID: 12208554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
    Daniel WA; Syrek M; Ryłko Z; Kot M
    Pol J Pharmacol; 2001; 53(6):615-21. PubMed ID: 11985335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antidepressant drugs on cytochrome P450 2C11 (CYP2C11) in rat liver.
    Wójcikowski J; Haduch A; Daniel WA
    Pharmacol Rep; 2013; 65(5):1247-55. PubMed ID: 24399720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human cytochrome P450 isoenzymes by a phenothiazine neuroleptic levomepromazine: An in vitro study.
    Basińska-Ziobroń A; Daniel WA; Wójcikowski J
    Pharmacol Rep; 2015 Dec; 67(6):1178-82. PubMed ID: 26481538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions.
    Danek PJ; Wójcikowski J; Daniel WA
    Pharmacol Rep; 2020 Dec; 72(6):1685-1694. PubMed ID: 32279279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma concentrations of bromperidol and its reduced metabolite with levomepromazine, but not with thioridazine.
    Suzuki A; Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Kaneko S; Inoue Y; Shibata M; Ikeda K
    Ther Drug Monit; 1997 Jun; 19(3):261-4. PubMed ID: 9200764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of amitriptyline and imipramine on the pharmacokinetics and metabolism of perazine in rats.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    J Pharm Pharmacol; 2000 Dec; 52(12):1473-81. PubMed ID: 11197075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of amitriptyline and carbamazepine on levomepromazine metabolism in human liver: an in vitro study.
    Wójcikowski J; Basińska A; Boksa J; Daniel WA
    Pharmacol Rep; 2014 Dec; 66(6):1122-6. PubMed ID: 25443744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats.
    Levine M; Law EY; Bandiera SM; Chang TK; Bellward GD
    J Pharmacol Exp Ther; 1998 Feb; 284(2):493-9. PubMed ID: 9454789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perazine at therapeutic drug concentrations inhibits human cytochrome P450 isoenzyme 1A2 (CYP1A2) and caffeine metabolism--an in vitro study.
    Wójcikowski J; Daniel WA
    Pharmacol Rep; 2009; 61(5):851-8. PubMed ID: 19904008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of rosuvastatin on liver microsomal CYP2C6 in hereditary hypertriglyceridemic rat.
    Vecera R; Zacharová A; Siller M; Matuskova Z; Skottová N; Anzenbacherová E; Anzenbacher P
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():48-52. PubMed ID: 23353843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.